google ads

Everything you need to know about Computed Tomography (CT) & CT Scanning

State-of-the-art Diagnosis and Treatment of Metastatic Melanoma: MDCT Protocol Optimization to Identify Metastases in Unusual Locations and Review of Innovative Therapeutic Agents


  1. Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9.
  2. Guy GP Jrr, et al. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR Morb Mortal Wkly Rep 2015; 64:591.
  3. Ekwueme DU et al. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity—United States, 2000 to 2006. J Am Acad Dermatol 2011; 65:S133–S143.
  4. Guy GP, et al. Prevalence and costs of skin cancer treatment in the US, 2002-2006 and 2007-2011. Am J Prev Med 2015; 48:183–7.
  5. Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893.
  6. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827.
  7. Patel JK, et al. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978; 135: 807–810.
  8. Trout AT et al. Melanoma metastases in the abdomen and pelvis: Frequency and patterns of spread. WJR 2013 5(2): 25-32.
  9. Bender GN, et al. Malignant melanoma: patterns of metastasis to the small bowel, reliability of imaging studies, and clinical relevance. Am J Gastroenterol 2001; 96(8):2392-2400.
  10. King DM. Imaging of Metastatic Melanoma. J HK Coll Radiol 2004 7:66-69.
  11. Winkler N, Rezvani M, Heilbrun M, Shaaban A. Utility of dual phase liver CT for metastatic melanoma staging and surveillance. Eur J Radiol. 2013 Dec;82(12):2189-93.
  12. Haider MA, Amitai MM, Rappaport DC, O'Malley ME, Hanbidge AE, Redston M, Lockwood GA, Gallinger S. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology. 2002 Oct;225(1):137-42
  13. Khan ZS, Huth J, Kapur P, Huerta S. Indications and recommended approach for surgical intervention of metastatic disease to the gallbladder. World J Surg Oncol. 2010 Sep 10;8:80.
  14. Perdona S, et al. A case of renal melanoma metastasis: description of clinico-pathological features. Arch Ital Urol Androl 2007; 79(4):161-163.
  15. Ozyuncu N et al. Cardiac metastasis of malignant melanoma: a rare case of complete atrioventricular block. Europace 2006; 8:545-548.
  16. Meunier R, Pareek G, Amin A. Metastasis of malignant melanoma to urinary bladder: A case report and review of the literature. Case Rep Path 2015; 2015: 6 pages, Article ID 173870.
  17. Liang K, et al. Metastatic malignant melanoma of the gastrointestinal tract. Mayo Clin Proc 2008; 81(4):511-516.
  18. Reccia I, et al. An uncommon presentation of metastatic melanoma: a case report. Medicine 2015; 94(7):1-4.
  19. Xiong Y, et al. Pelvis metastasis from primary choroidal melanoma: a case report. OncoTargets Ther 2014; 7:2107-2110.
  20. Junquels C, et al. An unusual digestive occlusion [French]. Rev Med Brux 2015 ; 36(1):42-44.
  21. Postow MA, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med 2015; 372:2006-2017.
  22. Maio M, et al. Five-year survival rates for treatment-naïve patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial. J Clin Oncol 2015; 33:1191-1196.
  23. Wyluda EJ, et al. Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy. Cancer Biol Ther 2015; 16(5):662-670.
  24. Johnson DB, et al. Combined BRAF (Dabrafenib) and MEK inhibition (trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor. J Clin Oncol 2014; 32:3697-3704.
  25. Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Medicine 2012; 10:23.
  26. Wasif N, Bagaria SP, Ray P, Morton DL. Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol. 2011;104:111–5.
  27. Petersen RP, Hanish SI, Haney JC, et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg. 2007;133:104–10.
  28. He M, et al. Post-Operative Survival Following Metastasectomy for Patients Receiving BRAF Inhibitor Therapy is Associated With Duration of Pre-Operative Treatment and Elective Indication. J Surg Onc. 2015;111:980–984.
  29. Singh D, et al. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung. J Thorac Dis 2014;6(4):369-374.
  30. Tirumani SH, et al. Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab. Cancer Immunol Res 2015 Jun 22. [Epub ahead of print]. Accessed 7/19/2015.
  31. Raad RA, et al. Imilimumab-induced hepatitis on 18F-FDG PET/CT in a patient with malignant melanoma. Clin Nucl Med 2015; 40:258-259.
  32. Bacanovic S, et al. Ipilimumab-induced adrenalitis: a possible pitfall in 18F-FDG PET/CT. Clin Nucl Med 2015 Jul 7 [Epub ahead of print]. Accessed 7/19/2015.
  33. Yu C, Chopra IJ, Ha E. A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis. Endocrinol Diab Metab Case Reports 2015 ;2015:140092.
  34. Fishman EK, et al. CT of malignant melanoma in the chest, abdomen, and musculoskeletal system. RadioGraphics 1990; 10:603-620.
  35. Nishino M, et al. Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome. J ImmunoTherapy Cancer 2014, 2:40.
  36. Shrot S, et al. CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastases. Eur Radiol 2014; 24:1251–1256.
  37. Beaino W, Nedrow JR, Anderson CJ. Evaluation of 68Ga- and 177Lu-DOTA-PEG4‑LLP2A for VLA-4-targeted PET imaging and treatment of metastatic melanoma. Mol Pharmaceutics 2015; 12: 1929−1938.
  38. Carling U, et al. Transarterial chemoembolization of liver metastases from uveal melanoma using irinotecan-loaded beads: treatment tesponse and complications. Cardiovasc Intervent Radiol 2015 Apr 2. [Epub ahead of print] . Accessed 7/19/2015.
  39. Schelhorn J, et al. A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma. Acta Radiologica Open 2015; 4(4): 1–7.
  40. Pfluger T, Melzer HI, Schneider V, La Fougere C, Coppenrath E, Berking C, Bartenstein P, Weiss M. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT. Eur J Nucl Med Mol Imaging. 2011 May;38(5):822-31.


© 1999-2019 Elliot K. Fishman, MD, FACR. All rights reserved.